Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease

Bioorganic & Medicinal Chemistry Letters
2014.0

Abstract

Structural homology between thrombin inhibitors and the early tetrapeptide HCV protease inhibitor led to the bioisosteric replacement of the P2 proline by a 2,4-disubstituted azetidine within the macrocyclic β-strand mimic. Molecular modeling guided the design of the series. This approach was validated by the excellent activity and selectivity in biochemical and cell based assays of this novel series and confirmed by the co-crystal structure of the inhibitor with the NS3/4A protein (PDB code: 4TYD).

Knowledge Graph

Similar Paper

Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
Bioorganic & Medicinal Chemistry Letters 2014.0
Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro
Bioorganic & Medicinal Chemistry 2015.0
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2–P1′ Region
ACS Medicinal Chemistry Letters 2014.0
Inhibitors of hepatitis C virus NS3·4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics
Bioorganic & Medicinal Chemistry Letters 2007.0
Achiral Pyrazinone-Based Inhibitors of the Hepatitis C Virus NS3 Protease and Drug-Resistant Variants with Elongated Substituents Directed Toward the S2 Pocket
Journal of Medicinal Chemistry 2014.0
Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease
Bioorganic & Medicinal Chemistry Letters 2010.0
The Design, Synthesis, and Antiviral Activity of 4′-Azidocytidine Analogues against Hepatitis C Virus Replication: The Discovery of 4′-Azidoarabinocytidine
Journal of Medicinal Chemistry 2009.0
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety
Bioorganic & Medicinal Chemistry 2008.0